Genomic and immune profiling of prognostic risk groups in IgM gammopathy reveals novel biomarkers beyond MYD88 L265P by David F. Moreno, David F. Moreno, Ferran Nadeu, Ferran Nadeu, Fara Brasó-Maristany, Fara Brasó-Maristany, Fara Brasó-Maristany, Sergi Vaqué, Sara Paz, Joan Mañé, Oriol Cardús, Elena Medina, Ester Lozano, Ester Lozano, Luis Gerardo Rodríguez-Lobato, Luis Gerardo Rodríguez-Lobato, Anna de Daniel, Anna de Daniel, Natalia Tovar, María T. Cibeira, Joan Bladé, Laura Rosiñol, Aleix Prat, Aleix Prat, Aleix Prat, Aleix Prat, Dolors Colomer, Dolors Colomer, Dolors Colomer, Carlos Fernández de Larrea, Carlos Fernández de Larrea

Get full text

ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27 by Yong Wang, Yanan Wang, Lei Bao, Goncalo Vale, Jeffrey G. McDonald, Yisheng Fang, Yan Peng, Ashwani Kumar, Chao Xing, Fara Brasó-Maristany, Aleix Prat, Carlos L. Arteaga, Yingfei Wang, Weibo Luo

Get full text

Publisher Correction: ZMYND8 drives HER2 antibody resistance in breast cancer via lipid control of IL-27 by Yong Wang, Yanan Wang, Lei Bao, Goncalo Vale, Jeffrey G. McDonald, Yisheng Fang, Yan Peng, Ashwani Kumar, Chao Xing, Fara Brasó-Maristany, Aleix Prat, Carlos L. Arteaga, Yingfei Wang, Weibo Luo

Get full text

Paclitaxel-related type I Kounis Syndrome in a very young patient with HER2-positive breast cancer and the role of genomics to disentangle a complex therapeutic scenario: a case re... by Javier Muñoz, Sabrina Nucera, Nuria Rubira Garcia, Isaac Cebrecos, Gabriela Oses, Sergi Ganau, Esther Sanfeliu, Pedro Jares, Mercedes Marín-Aguilera, Patricia Galván, Fara Brasó-Maristany, Olga Martínez-Sáez, Enric Cascos, Carme Font, Francesco Schettini

Get full text

Deciphering the transcriptomic landscape of early HR+/HER2− breast cancer in very young women by Iris Garrido‐Cano, Marta Tapia, Juan Carbonell, Carlos Peña, Sandra Torres‐Ruiz, Anna Ágreda‐Roca, Ana Lameirinhas, Cristina Tebar, Octavio Burgués, Cristina Hernando, Ana Lluch, Fara Brasó‐Maristany, Aleix Prat, Begoña Bermejo, María Teresa Martínez, Juan Miguel Cejalvo

Get full text

HER2DX ERBB2 mRNA score in first-line advanced HER2-positive breast cancer treated with chemotherapy, trastuzumab, and pertuzumab by Rodrigo Sánchez-Bayona, Olga Martínez-Sáez, Denys Romero-Romero, Elia Seguí, Esther Carcelero, Pablo Tolosa, Jesús Soberino, Manuel Alva, Tomás Pascual, Laura Lema, Isabel Garcia-Fructuoso, Maria Angeles Cobos-Fernandez, Maria Rey, Luis Manso, Angela Aguirre, Ainhoa Madariaga, Valeria Sirenko, Cristina González-Deza, Paula Blasco, Astrid Mayhua, Oleguer Castillo, Patricia Galván, Esther Sanfeliu, Guillermo Villacampa, Wesley Buckingham, Mercedes Marín-Aguilera, Laia Paré, Patricia Villagrasa, Charles M. Perou, Julia Maues, Fara Brasó-Maristany, Eva Ciruelos, Aleix Prat

Get full text